Company expects inflation to peak in its upcoming first quarter and decelerate the rest of the year.

Management said supply chain issues eased during the second quarter.

Ingredient portfolio offers better-for-you options.

Kinder Bueno sales in North America are approximately $167 million.

The testimonies of the FDA and Abbott Nutrition cast a negative light on both parties. 

Resilience, predictability and adaptability stand out.

It comes down to pivoting, preparation, plant proteins, personalization and predictions.

Company has more demand than it can currently service.

Management’s focus is shifting to closing market share gaps with category leaders.

Supply chain disruptions have weighed on the company’s pet food business.